[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_1886 

# __Vaccine hesitancy__

## Articles mentionning the risk

* [Digital Twin of COVID-19 Mass Vaccination Centers](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_47.md)
* [Panneer_health_2022](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_617.md)

## Category to which it belongs

* [Limited capacity, high demand, waning effectiveness, distribution difficulties, and access disparities hinder efficient vaccination efforts.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_75.md)

## Closest similar item

* [Demand for vaccine development](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3118.md)
* [Difficulty in vaccine distribution](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1733.md)
* [Expectations for vaccine](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1888.md)
* [Hesitation to vaccinate](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_430.md)
* [Inadequate vaccination coverage](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2277.md)
* [Inadequate vaccine efficacy](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_423.md)
* [Lack of covid-19 vaccine](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_519.md)
* [Lack of drugs and vaccines](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1341.md)
* [Lack of vaccine or cure](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3186.md)
* [Vaccine availability, vaccine hesitancy](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2056.md)

## Description of the risk

Vaccine hesitancy can hinder the success of vaccination campaigns, leading to lower vaccine uptake and continued transmission of contagious diseases.

## Is the risk affecting GBN scales

* [No](https://github.com/mm80843/T3.5/blob/pages/ISO_Scale/PBN__ISO_Scale_0.md)

## Mitigations of this risk

* [Culturally tailored communication, community engagement, and robust pharmacovigilance to address concerns and build trust](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_2507.md)
* [Implement effective communication and education campaigns to address vaccine hesitancy, provide accurate information, and address concerns and misconceptions. engage with local communities and healthcare providers.](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_18826.md)

## Name of the risk

Lower vaccine uptake, increased risk of disease transmission, potential outbreaks.

## People affected by this risk

* [Communities](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_9.md)
* [Especially in low-income and high-income countries](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_29.md)
* [General population](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_4.md)
* [General public](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_13501.md)

## Stakeholders who can mitigate this risk

* [And public health organizations](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_73.md)
* [Community leaders](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_394.md)
* [Government](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_216.md)
* [Health authorities](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_604.md)
* [Healthcare organizations](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2693.md)

## Technologies linked to the risk

* [And adverse event monitoring systems](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_1300.md)
* [Communication campaigns](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_31.md)
* [Community engagement initiatives](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_1155.md)
* [Data analytics for tailored messaging](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_1301.md)
* [Public awareness programs](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_19272.md)
* [Social media monitoring](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_19273.md)

## This Risk belongs to this RiskGroup

* [Public health risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_3.md)

## This Risk belongs to this RiskSubgroup

* [Failure to implement preventive measures](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_12.md)

## Type of impact of the risk (according to ISO37100)

* [Living and working environment](https://github.com/mm80843/T3.5/blob/pages/ISO_Purpose/PBN__ISO_Purpose_1.md)

## Type of purpose of the risk (according to ISO37100)

* [Resilience](https://github.com/mm80843/T3.5/blob/pages/ISO_Impact/PBN__ISO_Impact_2.md)

## Type of the risk

* [Physical](https://github.com/mm80843/T3.5/blob/pages/RiskHealth/PBN__RiskHealth_0.md)

## Property: has_RiskType

* [Health](https://github.com/mm80843/T3.5/blob/pages/RiskType/PBN__RiskType_2.md)
* [Social](https://github.com/mm80843/T3.5/blob/pages/RiskType/PBN__RiskType_4.md)

